Hypoglycemic effect of ouabain in dogs.
D000067956:Adenylyl Cyclase Inhibitors; D000273:Adipose Tissue / Q000378:metabolism; D000704:Analysis of Variance; D000818:Animals; D003864:Depression, Chemical; D004285:Dogs; D004837:Epinephrine / Q000037:antagonists & inhibitors; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005990:Glycerol / Q000097:blood; D006019:Glycolysis / Q000187:drug effects; D007003:Hypoglycemia / Q000139:chemically induced*; D007328:Insulin / Q000502:physiology; D050356:Lipid Metabolism; D008112:Liver Glycogen / Q000378:metabolism; D008297:Male; D010042:Ouabain; D010101:Oxygen Consumption
D000067956:Adenylyl Cyclase Inhibitors; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D008112:Liver Glycogen; D010042:Ouabain; D005990:Glycerol; D004837:Epinephrine